» Articles » PMID: 35637657

Clinical Factors Associated with Serum Magnesium Concentration in Patients Undergoing Peritoneal Dialysis: A Single-Center Observational Study

Overview
Publisher Dove Medical Press
Specialty Nephrology
Date 2022 May 31
PMID 35637657
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Magnesium (Mg) is an essential element that is associated with various physiological functions, such as maintenance of blood pressure, muscle contraction, and nerve function. In patients undergoing hemodialysis, hypomagnesemia is associated with cardiovascular and all-cause mortality. However, in patients undergoing peritoneal dialysis (PD), clinical factors associated with Mg have not been fully investigated.

Patients And Methods: Clinical factors including anthropometric data, comorbidities, laboratory data, medications, and dialysis methods were collected from the medical records of patients undergoing PD. The associations of these factors with the serum Mg concentration were investigated by univariate and multivariate analyses.

Results: Sixty patients undergoing PD were investigated. The univariate analysis showed that the serum Mg concentration was significantly associated with treatment by hybrid PD (daily PD + once-weekly hemodialysis) (β = 0.264, P = 0.04), administration of phosphate binders (β = 0.294, P = 0.02), the serum C-reactive protein concentration (β = -0.318, P = 0.01), the serum potassium (K) concentration (β = 0.451, P < 0.01), and the serum intact parathormone concentration (β = -0.333, P = 0.01). The multivariate analysis using these factors showed an independent association between the serum Mg and K concentrations (β = 0.333, P = 0.01).

Conclusion: The serum Mg concentration was independently associated with the serum K concentration in patients undergoing PD.

Citing Articles

Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium.

Li P, Lv T, Xu L, Yu W, Lu Y, Li Y Ren Fail. 2024; 46(1):2355354.

PMID: 38785302 PMC: 11132858. DOI: 10.1080/0886022X.2024.2355354.


Influencing factors of serum magnesium in CKD5 patients: A multicenter study in southern China.

Wang J, Lin S, Li H, Tang W, Liu Y, Zhou T Front Public Health. 2023; 10:1047602.

PMID: 36589976 PMC: 9794747. DOI: 10.3389/fpubh.2022.1047602.

References
1.
Cho M, Lee K, Lee Y, Ma S, Ko J, Kim S . Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J Intern Med. 2002; 17(2):114-21. PMC: 4531662. DOI: 10.3904/kjim.2002.17.2.114. View

2.
Gug C, Mihaescu A, Mozos I . Two mutations in the thiazide-sensitive NaCl co-transporter gene in a Romanian Gitelman syndrome patient: case report. Ther Clin Risk Manag. 2018; 14:149-155. PMC: 5784745. DOI: 10.2147/TCRM.S150483. View

3.
Foglia P, Bettinelli A, Tosetto C, Cortesi C, Crosazzo L, Edefonti A . Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome). Nephrol Dial Transplant. 2004; 19(6):1398-402. DOI: 10.1093/ndt/gfh204. View

4.
van de Wal-Visscher E, Kooman J, van der Sande F . Magnesium in Chronic Kidney Disease: Should We Care?. Blood Purif. 2018; 45(1-3):173-178. PMC: 6492639. DOI: 10.1159/000485212. View

5.
Bokhari S, Siriki R, Teran F, Batuman V . Fatal Hypermagnesemia Due to Laxative Use. Am J Med Sci. 2018; 355(4):390-395. DOI: 10.1016/j.amjms.2017.08.013. View